Finance

Lists
Why is ACT up 2.08%?
Dive Deeper
ACT:NASDAQ
Enact Holdings Inc
$46.20
+2.08%
(+0.94) 1D
Oct 5, 12:53:46 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACT...
Open
$45.63
High
$46.24
Low
$45.23
Mkt. cap
6.35B
Avg. vol.
430.80K
Volume
72.91K
Dividend
2.08%
Quarterly dividend
$0.24
Ex-dividend date
Aug 20, 2026
P/E ratio
9.74
52-wk high
$50.56
52-wk low
$34.64
EPS
$4.74
Beta
0.51
Shares outstanding
137.48M
No. of employees
419
Open
$45.63
High
$46.24
Low
$45.23
Mkt. cap
6.35B
Avg. vol.
430.80K
Volume
72.91K
Dividend
2.08%
Quarterly dividend
$0.24
Ex-dividend date
Aug 20, 2026
P/E ratio
9.74
52-wk high
$50.56
52-wk low
$34.64
EPS
$4.74
Beta
0.51
Shares outstanding
137.48M
No. of employees
419
News stories
From web sources and news partners
About Enact Holdings Inc
CEO-
Employees419
Founded2012
Headquarters-
SectorFinancial services
Websiteenactmi.com
Analyst ratings
Based on 4 analysts giving stock ratings to ACT in the past 3 months
Hold
Buy
0
Hold
4
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ACT in the last 3 months.
Highest
Current $46.20
$50.00 (+8.23%)
Average
$48.00 (+3.90%)
Lowest
$46.00 (-0.43%)
Analyst
Recommendation
Action
Price target
Projected
Date
Bose George
KBW
Hold
Maintained
-
-
09/25/2026
Douglas Harter
BTIG
Hold
Initiated
-
-
09/25/2026
Rowland Mayor
RBC Capital
Hold
Maintained
$50.00
+8.2%
08/06/2026
Richard Shane
J.P. Morgan
Hold
Reiterated
$46.00
-0.4%
07/13/2026
Mihir Bhatia
Bank of America Securities
Buy
Maintained
$46.00
-0.4%
05/06/2026
Ryan Nash
Goldman Sachs
Hold
Maintained
$50.00
+8.2%
02/05/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$1.26 / $1.19
+6.12%beat
Revenue / Est. (USD)
317.31M / 315.81M
+0.47%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
311.46M
312.71M
312.07M
317.31M
Cost of goods sold
88.54M
77.13M
86.32M
84.85M
Cost of revenue
88.54M
77.13M
86.32M
84.85M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
88.54M
77.13M
86.32M
84.85M
Operating income
222.92M
235.58M
225.75M
232.45M
Other non operating income
-
-
-
-
EBT including unusual items
209.83M
223.08M
213.38M
219.97M
EBT excluding unusual items
210.02M
223.11M
213.38M
219.97M
Income tax expense
46.33M
45.92M
45.61M
45.13M
Effective tax rate
22.08%
20.59%
21.37%
20.52%
Other operating expenses
-
-
-
-
Net income
163.50M
177.16M
167.77M
174.84M
Net profit margin
52.49%
56.65%
53.76%
55.10%
Earnings per share
1.12
1.23
1.21
1.26
Interest and investment income
-
-
-
-
Interest expense
-12.90M
-12.46M
-12.37M
-12.48M
Net interest expenses
-12.90M
-12.46M
-12.37M
-12.48M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps